Arbutus Biopharma
ABUS
#7151
Rank
A$0.92 B
Marketcap
A$6.05
Share price
1.49%
Change (1 day)
-12.94%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): A$1.18

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A$1.21. In 2025 the company made an earnings per share (EPS) of A-$0.25 an increase over its 2024 EPS that were of A-$0.56.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.18-570.37%
2025A-$0.25-55.26%
2024A-$0.56-13.64%
2023A-$0.65-4.35%
2022A-$0.68-44.58%
2021A-$1.23-17%
2020A-$1.48-65.4%
2019A-$4.28138.84%
2018A-$1.79-22.44%
2017A-$2.31-78.45%
2016A-$10.71424.64%
2015A-$2.04-20.19%
2014A-$2.5687.96%
2013A-$1.36-142.59%
2012A$3.20-342.7%
2011A-$1.32-25.82%
2010A-$1.7747.8%
2009A-$1.20-43.55%
2008A-$2.13158.91%
2007A-$0.82-111.88%
2006A$6.92-552.53%
2005A-$1.53-71.77%
2004A-$5.41-14.48%
2003A-$6.33-8.95%
2002A-$6.9570.07%
2001A-$4.0948.01%
2000A-$2.76-38.54%
1999A-$4.49-24.6%
1998A-$5.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.08876-107.32% Bahamas
NRC Health
NRC
A$0.43-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA